Patient info Open main menu

Matoride XL 36 mg prolonged-release tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Controlled drug (Schedule 2) Details

Medicine strength:
36 mg
Contains active substance:

Patient leaflet - Matoride XL 36 mg prolonged-release tablets

1. What Matoride XL is and what it is used for 2. What you need to know before you or your child takes

Matoride XL

  1. 3. How to take Matoride XL
  2. 4. Possible side effects
  3. 5. How to store Matoride XL
  4. 6.

    1 What Matoride XL is and what it is used

    for

What it is used for

Matoride XL is used to treat ‘Attention Deficit Hyperactivity Disorder’ (ADHD).

  • It is used in children and adolescents aged between 6 years over and in adults.
  • It is used only after trying treatments which do not involve medicines, such as counselling and behavioural therapy.

    Matoride XL is not for use as a treatment for ADHD in children under 6 years of age.

How it works

Matoride XL improves the activity of certain parts of the brain which are under-active. The medicine can help improve attention (attention span), concentration and reduce impulsive behaviour.

The medicine is given as part of a treatment programme, which usually includes:

  • psychological
  • educational and
  • social therapy

It is prescribed only by doctors who have experience in children and adolescents or adults with behaviour problems. If you are an adult and have not been treated before, the specialist will carry out tests to confirm that you have had ADHD since childhood. Although there is no cure for ADHD, it can be managed using treatment programmes.

About ADHD

Children and adolescents with ADHD find it:

  • hard to sit still and
  • hard to concentrate

It is not their fault that they cannot do these things. Many children and adolescents struggle to do these things. However, ADHD can cause problems with everyday life. Children and adolescents with ADHD may have difficulty learning and doing homework. They find it hard to behave well at home, at school or in other places.

Adults with ADHD often find it hard to concentrate. They often feel restless, impatient and inattentive.

They may have difficulty organising their private life and work.

Not all patients with ADHD need to be treated with medicine.

ADHD does not affect intelligence.

2 What you need to know before you or

your child takes Matoride XL

Do not take Matoride XL if you or your child

  • is allergic to methylphenidate or any of the other ingredients of this medicine (listed in section 6).
  • has a thyroid problem
  • has increased pressure in the eye (glaucoma)
  • has a tumour of the adrenal gland

    (phaeochromocytoma)

  • has an eating problem when you do not feel hungry or want to eat - such as ‘anorexia nervosa’
  • has very high blood pressure or narrowing of the blood vessels, which can cause pain in the arms and legs
  • has ever had heart problems - such as a heart attack, uneven heartbeat, pain and discomfort in the chest, heart failure, heart disease or was born with a heart problem
  • has had a problem with the blood vessels in the brain such as a stroke, swelling and weakening of part of a blood vessel (aneurysm), narrow or blocked blood vessels, or inflammation of the blood vessels (vasculitis)
  • is currently taking or has taken within the last 14 days an antidepressant (known as a monoamine oxidase inhibitor) - see “Other medicines and Matoride XL”.
  • has mental health problems such as:

    • a ‘psychopathic’ or ‘borderline personality’ problem
    • abnormal thoughts or visions or an illness called

      ‘schizophrenia’

    • signs of a severe mood problem like:

      • feeling like killing yourself
      • severe depression, where you feel very sad,

        worthless and hopeless

      • mania, where you feel unusually excitable,

        overactive and uninhibited

Do not take methylphenidate if any of the above apply to you or your child. If you are not sure, talk to your doctor or pharmacist before you or your child takes methylphenidate. This is because methylphenidate can make these problems worse.

Warnings and precautions

Talk to your doctor before taking Matoride XL if you or your child:

  • have/has liver or kidney problems
  • have/has problems with swallowing or swallowing whole tablets
  • have/has a narrowing or blockage of the gut or food-pipe
  • have/has had fits (seizures, convulsions, epilepsy) or any abnormal brain scans (EEGs)
  • have/has had increased pressures in the eye (intraocular pressure)
  • have/has ever abused or been dependent on alcohol, prescription medicines or street drugs
  • is a girl and has started having periods (see the ‘Pregnancy and breast-feeding’ section below)
  • have/has hard-to-control, repeated twitching of any parts of the body or repeats sounds and words
  • have/has high blood pressure
  • have/has a heart problem which is not in the ‘Do not take’ section above
  • have/has a mental health problem which is not in the ‘Do not take’ section above

    Other mental health problems include:

    • mood swings (from being manic to being depressed

      called ‘bipolar disorder’)

    • feeling aggressive or hostile
    • seeing, hearing or feeling things that are not there

      (hallucinations)

    • believing things that are not true (delusions)
    • feeling unusually suspicious (paranoia)
    • feeling agitated, anxious or tense
    • feeling depressed or guilty

Tell your doctor or pharmacist if any of the above apply to you or your child before starting treatment. This is because Matoride XL can make these problems worse. Your doctor will want to monitor how the medicine affects you or your child.

During treatment, boys and adolescents may unexpectedly experience prolonged erections. This may be painful and can occur at any time. It is important to contact your doctor straight away if your erection lasts for longer than 2 hours, particularly if this is painful.

If you or your child develop blurred vision or other visual disturbances contact your doctor. Your doctor may consider discontinuation of Matoride XL.

Checks that your doctor will make before you or your child starts taking Matoride XL

These checks are to decide if Matoride XL is the correct medicine for you or your child. Your doctor will talk to you about:

  • any other medicines you or your child is taking
  • whether there is any family history of sudden unexplained death
  • any other medical problems (such as heart problems) you or your family may have
  • how you or your child is feeling, such as feeling high or low, having strange thoughts or if you or your child has had any of these feelings in the past
  • whether there is a family history of ‘tics’ (hard-to-control, repeated twitching of any parts of the body or repeating sounds and words)
  • any mental health or behaviour problems you or your child or other family members have ever had. Your doctor will discuss whether you or your child is at risk of having mood swings (from being manic to being depressed - called ‘bipolar disorder’). They will check

    yours or you or your child’s mental health history, and check if any of your family have a history of suicide, bipolar disorder or depression.

    It is important that you provide as much information as you can. This will help your doctor decide if methylphenidate is the correct medicine for you or your child. Your doctor may decide that other medical tests are needed before you or your child start taking this medicine. For adult patients that are new to [Nationally completed name], your doctor may refer you to a heart specialist.

    Other medicines and Matoride XL

    Tell your doctor if you or your child is taking, have recently taken or might take any other medicines.

    Do not take methylphenidate if you or your child:

    • is taking a medicine called a ‘monoamine oxidase inhibitor’ (MAOI) used for depression, or has taken an MAOI in the last 14 days

      Taking an MAOI with methylphenidate may cause a sudden increase in blood pressure (see “Do not take Matoride XL”).

      Tell your doctor or pharmacist if you or your child is taking any of the following medicines for depression or anxiety:

      • tricyclic antidepressant
      • selective serotonin reuptake inhibitor (SSRI)
      • serotonin and norepinephrine reuptake inhibitor’ (SNRI). Taking methylphenidate with these types of medicine could cause a life-threatening increase of ‘serotonin’ in the brain (serotonin syndrome), which may lead to feeling confused or restless, sweating, shivering, muscle jerks or fast heartbeat. If you or your child develops these side effects, see a doctor straight away.

If you or your child is taking other medicines, methylphenidate may affect how well they work or may cause side effects. If you or your child is taking any of the following medicines, check with your doctor or pharmacist before taking methylphenidate:

  • medicines for severe mental health problems
  • medicines for Parkinson’s disease (such as levodopa)
  • medicines for epilepsy
  • medicines used to reduce or increase blood pressure
  • some cough and cold remedies which contain medicines that can affect blood pressure

    It is important to check with your pharmacist when you buy any of these products.

  • medicines that thin the blood to prevent blood clots

If you are in any doubt about whether any medicines you or your child is taking are included in the list above, ask your doctor or pharmacist for advice before taking methylphenidate.

Please tell your doctor or pharmacist if you or your child is taking or has recently taken any other medicines, including medicines obtained without a prescription.

Having an operation

Tell your doctor if you or your child is going to have an operation. Methylphenidate should not be taken on the day of surgery if a certain type of anaesthetic is used. This is because there is a chance of a sudden rise in blood pressure and heart rate during the operation. Drug testing

This medicine may give a positive result when testing for drug use. This includes testing used in sport. Matoride XL with alcohol

Do not drink alcohol while taking this medicine. Alcohol may make the side effects of this medicine worse. Remember that some foods and medicines contain alcohol.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a

baby, ask your doctor for advice before taking this medicine.

Available data do not suggest an increased risk of overall birth defects, whilst a small increase in the risk of malformations of the heart when used during the first three months of pregnancy could not be ruled out. Your doctor will be able to give you more information about this risk. Tell your doctor or pharmacist before using methylphenidate if you are or your daughter is:

  • having sex. Your doctor will discuss contraception
  • pregnant or think might be pregnant.

    Your doctor will decide whether methylphenidate should be taken.

  • breast-feeding or planning to breast-feed.

    Methylphenidate passes into breast milk. Therefore, your doctor will decide whether you or your daughter should breast-feed while taking methylphenidate. Driving and using machines

You or your child may feel dizzy, have problems focussing or have blurred vision when taking methylphenidate. If these happen it may be dangerous to do things such as drive, use machines, ride a bike or horse or climb trees.

This medicine can affect your ability to drive as it may make you sleepy or dizzy.

  • Do not drive while taking this medicine until you know how it affects you.
  • It is an offence to drive if this medicine affects your ability to drive.
  • However, you would not be committing an offence if:

    • The medicine has been prescribed to treat a medical or dental problem and
    • You have taken it according to the instructions given by the prescriber or in the information provided with the medicine and
    • It was not affecting your ability to drive safely

Talk to your doctor or pharmacist if you are not sure whether it is safe for you to drive while taking this medicine. Matoride XL contains lactose and sodium

If you or your child has been told by your doctor that you or your child has an intolerance to some sugars, contact your doctor before taking this medicine.

This medicine contains less than 1 mmol sodium (23 mg) per prolonged-release tablet, that is to say essentially ‘sodium-free’.

3 How to take Matoride XL

How much to take

You or your child should always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.

  • Your doctor will usually start treatment with a low dose and increase the daily dose by 18mg no sooner than once a week if necessary
  • The aim should be the lowest dose that is effective for you or your child. Your doctor will decide the maximum daily dose for you or your child.
  • You or your child should take Matoride XL once each day in the morning with a glass of water.

    The tablet should be swallowed whole and not chewed, broken, or crushed. The tablet may be taken with or without food.

The tablet does not dissolve completely after all of the active substance has been released and sometimes the tablet shell may appear in the stools. This is normal. Use in children aged 6 years and over

  • the recommended starting dose of Matoride XL is 18 mg once daily for children who are not currently taking methylphenidate or for children who are switching from another stimulant to methylphenidate
  • the maximum daily dose is 54 mg.

Use in adults

  • the maximum daily dose in adults is 72 mg. For adults who have taken [Nationally completed name] before:
  • if you have already taken [Nationally completed name] as a child or adolescent, the same daily dosage (mg/ day) can be used; your doctor will check regularly to see if any adjustment is required.
Variation:V046 – Reference product adaptionTechnical Colours:
004.0Legend:
Date prepared:26/10/2025Cutting:
8 ptTextArea:
HelveticaGuides:
165x620 mm
Technical data:
SKUs:00000000
SZ codes:00000000
00000000Colours:
00000
  • adult patients may require a higher daily dose but the doctor will aim to give you the lowest dose that is effective.

For adults who have not taken [Nationally completed name] before:

  • the recommended starting dose is 18 mg daily. If you or your child does not feel better after 1 month of treatment

If you or your child do/does not feel better after 1 month of treatment tell your doctor. Your doctor may decide that you or your child needs a different treatment.

Not using Matoride XL properly

If Matoride XL is not used properly, this may cause abnormal behaviour. It may also mean that you or your child starts to depend on the medicine. Tell your doctor if you or your child has ever abused or been dependent on alcohol, prescription medicines or street drugs. This medicine is only for you or your child. Do not give this medicine to anyone else, even if their symptoms seem similar.

If you or your child takes more Matoride XL than you should

If you or your child takes too much medicine, talk to a doctor or call an ambulance straight away. Tell them how much has been taken. Medical treatment might be needed.

Signs of overdose may include:

  • being sick,
  • feeling agitated,
  • shaking,
  • increased uncontrolled movements,
  • muscle twitching,
  • fits (may be followed by coma),
  • feeling very happy,
  • being confused,
  • seeing, feeling or hearing things that are not real (hallucinations),
  • sweating,
  • flushing,
  • headache,
  • high fever,
  • changes in heart beat (slow, fast or uneven),
  • high blood pressure,
  • dilated pupils,
  • dry nose and mouth.

If you or your child forgets to take Matoride XL

Do not take a double dose to make up for a forgotten dose. If you or your child forgets a dose, wait until it is time for the next dose.

If you or your child stops taking Matoride XL

If you or your child suddenly stops taking this medicine, ADHD symptoms may come back or unwanted effects such as depression may appear. Your doctor may want to gradually reduce the amount of medicine taken each day, before stopping it completely. Talk to your doctor before stopping Matoride XL.

Things your doctor will do when you or your child is on treatment

Your doctor will do some tests

  • before you or your child starts - to make sure that Matoride XL is safe and will be of benefit
  • after you or your child starts - they will be done at least every 6 months, but possibly more often.

They will also be done when the dose is changed.

  • these tests will include:

    • checking appetite
    • measuring height and weight
    • measuring blood pressure and heart rate
    • checking problems with mood, state of mind or any

      other unusual feelings.

      Or if these have got worse while taking Matoride XL.

  • Long-term treatment

    Matoride XL does not need to be taken forever. If you or your child takes Matoride XL for more than a year, your doctor should stop treatment for a short time, this may happen during a school holiday. This will show if the medicine is still needed.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4 Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Although some people get side effects, most people find that methylphenidate helps them. Your doctor will talk to you about these side effects.

Some side effects could be serious. If you or your child has any of the side effects below, see a doctor straight away:

Common (may affect up to 1 in 10 people)

  • uneven heartbeat (palpitations)
  • mood changes or mood swings or changes in personality

Uncommon (may affect up to 1 in 100 people)

  • thinking about or feeling like killing yourself
  • seeing, feeling or hearing things that are not real, these are signs of psychosis
  • uncontrolled speech and body movements (Tourette’s)
  • signs of allergy such as rash, itching or hives on the skin, swelling of the face, lips, tongue or other parts of the body, shortness of breath, wheezing or trouble breathing

Rare (may affect up to 1 in 1,000 people)

  • feeling unusually excited, over-active and un-inhibited (mania)

Very rare (may affect up to 1 in 10,000 people)

  • heart attack
  • sudden death
  • suicidal attempt
  • fits (seizures, convulsions epilepsy)
  • skin peeling or purplish red patches
  • inflammation or blocked arteries in the brain
  • temporary paralysis or problems with movement and vision, difficulties in speech (these can be signs of problems with the blood vessels in your brain)
  • muscle spasms which you cannot control affecting your eyes, head, neck, body and nervous system
  • decrease in number of blood cells (red cells, white cells and platelets) which can make you more likely to get infections, and make you bleed and bruise more easily
  • a sudden increase in body temperature, very high blood pressure and severe convulsions (‘Neuroleptic Malignant Syndrome’). It is not certain that this side effect is caused by methylphenidate or other medicines that may be taken in combination with methylphenidate. Not known (frequency cannot be estimated from the available data)
  • unwanted thoughts that keep coming back
  • unexplained fainting, chest pain, shortness of breath (these can be signs of heart problems)
  • prolonged erections, sometimes painful or an increased number of erections.

If you or your child has any of the side effects above, see a doctor straight away.

Other side effects include the following, if they get serious, please tell your doctor or pharmacist:

Very common (may affect more than 1 in 10 people)

  • headache
  • feeling nervous
  • not being able to sleep.
  • nausea
  • dry mouth

Common (may affect up to 1 in 10 people)

  • joint pain
  • blurred vision
  • tension headache
  • thirst
  • trouble falling asleep
  • high temperature (fever)
  • decreased sex drive
  • unusual hair loss or thinning
  • muscle tightness, muscle cramps
  • loss of appetite or decreased appetite
  • inability to develop or maintain an erection
  • itching, rash or raised red itchy rashes (hives)
  • feeling unusually sleepy or drowsy, feeling tired
  • excessive teeth grinding (bruxism)
  • feeling of panic
  • tingling feeling, prickling, or numbness of the skin
  • increased alanine aminotransferase (liver enzyme) level in your blood
  • cough, sore throat or nose and throat irritation, upper respiratory tract infection; sinus infection
  • high blood pressure, fast heart beat (tachycardia)
  • dizziness (vertigo), feeling weak, movements which you cannot control, being unusually active
  • feeling aggressive, agitated, anxious, depressed, irritable, tense, jittery and abnormal behaviour
  • upset stomach or indigestion, stomach pain, diarrhoea, stomach discomfort and being sick
  • excessive sweating
  • weight decreased

Uncommon (may affect up to 1 in 100 people)

  • dry eyes
  • constipation
  • chest discomfort
  • blood in the urine
  • listlessness
  • shaking or trembling
  • increased need to pass urine

    • muscle pain, muscle twitching
    • shortness of breath or chest pain
    • feeling hot
    • increases in liver test results (seen in a blood test)
    • anger, feeling restless or tearful, talking too much, excessive awareness of surroundings, problems sleeping

Rare (may affect up to 1 in 1,000 people)

  • problems with sex drive
  • feeling disorientated or confused
  • trouble seeing or double vision
  • swelling of the breasts in men
  • redness of the skin, red raised skin rash
  • obsessive-compulsive disorder (OCD) (including irresistible urge to pull out body hair, skin picking, having repeated unwanted thoughts, feelings, images or urges in your mind (obsessive thoughts), performing repeated behaviours or mental rituals (compulsions)) Very rare (may affect up to 1 in 10,000 people)
  • muscle cramps
  • small red marks on the skin
  • abnormal liver function including sudden liver failure and coma
  • changes in test results - including liver and blood tests
  • abnormal thinking, lack of feeling or emotion
  • cold feeling in the arms and legs
  • fingers and toes feeling numb, tingling and changing colour (from white to blue, then red) when cold (‘Raynaud’s phenomenon’)

Not known (frequency cannot be estimated from the available data)

  • migraine
  • dilated pupils
  • very high fever
  • slow, fast or extra heart beats
  • a major fit (‘grand mal convulsions’)
  • increased pressure in the eye
  • eye diseases which may cause decreased vision due to damage to the eye nerve (glaucoma) (damage to the nerves in the eye caused by high pressure due to clogging of fluid drainage canals damage to the nerve in the eye caused by pressure inside the eye rising rapidly because fluid cannot drain out)
  • believing things that are not true
  • severe stomach pain, often with feeling and being sick
  • problems with the blood vessels of the brain (stroke, cerebral arteritis or cerebral occlusion)
  • inability to control the excretion of urine (incontinence)
  • spasm of the jaw muscles that makes it difficult to open the mouth (trismus)
  • stuttering
  • nosebleed

Effects on growth

When used for more than a year, methylphenidate may cause reduced growth in some children. This affects less than 1 in 10 children.

  • There may be lack of weight gain or height growth.
  • Your doctor will carefully watch you or your child’s height and weight, as well as how well you or your child is eating.
  • If you or your child are not growing as expected, then treatment with methylphenidate may be stopped for a short time.

Reporting of side effects

If you or your child gets any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website:

www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5 How to store Matoride XL

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on carton and label after “EXP”. The expiry date refers to the last day of that month.

This medicine does not require any special storage conditions.

Storage conditions after first opening the bottle: Store below 25°C.

Shelf life after first opening of the bottle:

6 months

The pack contains drying plug. This plug is used to keep the prolonged-release tablets dry and should not be eaten.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6 Contents of the pack and other

information

What Matoride XL contains

The active substance is methylphenidate hydrochloride. Matoride XL 18mg prolonged-release tablets

Each prolonged-release tablet contains 18 mg of methylphenidate hydrochloride.

Matoride XL 36mg prolonged-release tablets

Each prolonged-release tablet contains 36 mg of methylphenidate hydrochloride.

Matoride XL 54mg prolonged-release tablets

Each prolonged-release tablet contains 54 mg of methylphenidate hydrochloride.

The other ingredients are:

  • drug layer: polyethylene oxide, succinic acid, povidone (K25), butylhydroxytoluene, stearic acid
  • push layer: polyethylene oxide, sodium chloride, povidone (K25), butylhydroxytoluene, iron oxide red (E 172), stearic acid
  • membrane layer: cellulose acetate, poloxamer 188
  • drug coat: hypromellose, succinic acid

    film coat: film coating mixture: white lactose monohydrate, hypromellose, titanium dioxide (E 171), macrogol 4000

    In addition in 18 mg prolonged release tablets: Iron oxide yellow (E 172)

    In addition in 54 mg prolonged release tablets: Iron oxide red (E 172)

    Iron oxide yellow (E 172)

What Matoride XL looks like and contents of the pack

Matoride XL 18mg prolonged-release tablets

Light yellow film-coated tablet of round shape (diameter 8 mm) with a delivery orifice (visible small round hole) on one side.

Matoride XL 36mg prolonged-release tablets

White film-coated tablet of round shape (diameter 10 mm) with a delivery orifice (visible small round hole) on one side. Matoride XL 54mg prolonged-release tablets Red film-coated tablet of round shape (diameter 10 mm) with a delivery orifice (visible small round hole) on one side.

The prolonged-release tablets are packed in high-density polyethylene (HDPE) bottles with a child-resistant polypropylene closure (PP screw cap) with drying plug.

The prolonged-release tablets are packed in blister foil (PVC/ PVDC-Foil /Aluminium-foil)

Pack size:

For HDPE Bottle:

28 or 30 prolonged-release tablets or

Multipacks: 60 (2x30) or 90 (3x30) prolonged-release tablets

For Blister foil:

10 prolonged-release tablets per blister [10 to 100 (plural of 10)]

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Sandoz Limited

Park View, Riverside Way

Watchmoor Park

Camberley, Surrey

GU15 3YL

United Kingdom

Manufacturer

Salutas Pharma GmbH,

Otto-von-Guericke-Allee 1, 39179 Barleben, Germany

or

Lek Pharmaceuticals d.d.,Trimlini 2D,9220 Lendava, Slovenia

or

Lek Pharmaceuticals d.d.,

Verovskova 57, 1526 Ljubljana,

Slovenia

This leaflet was last revised in 10/2025

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 04416/1348

Last revision stated in the text: October 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Matoride XL 36 mg prolonged-release tablets

Prescription needed? Yes, prescription-only medicine (POM)
Controlled drug
Yes, Schedule 2 of the Misuse of Drugs Regulations?
  • Controlled drugs are medicines that UK law controls more strictly because they can be misused or cause dependence. The Misuse of Drugs Regulations 2001 divide them into 5 schedules: schedule 1 has the strictest rules, schedule 5 the lightest.
  • Schedule 2 is the strictest group of prescribed medicines, for example strong opioid painkillers and medicines for ADHD.
  • A prescription is valid for 28 days and usually covers up to 30 days of treatment. It cannot be issued as a repeat dispensing prescription.
  • When you collect it, the pharmacist must check whether you are the patient and may ask for ID.
  • Travelling abroad: you can usually carry up to 3 months' supply. Take your prescription or a letter from your doctor to show it is yours, and check the rules of the country you are going to (GOV.UK).
  • Never give it to anyone else.
Active substance Methylphenidate
Strength 36 mg
Pharmaceutical form Modified-release tablet
White film-coated tablet of round shape (diameter 10mm) with a delivery orifice (visible round small hole) on one side.
How is it taken Oral
Excipients Drug layer, Polyethylene oxide, Succinic acid, Povidone (K25), Butylhydroxytoluene, Stearic acid, Push layer, Sodium chloride, Iron oxide red (E 172), Membrane layer, Cellulose acetate, Poloxamer 188, Drug coat, Hypromellose, Lactose monohydrate, Titanium dioxide (E 171), Macrogol 4000, Iron oxide yellow (E 172)
Pack sizes 30 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life For HDPE Bottle:
3 years
For Blister foil:
18 months
Shelf-life after first opening of the bottle:
6 months.
Storage conditions after first opening of the bottle:
Store below 25°C.
Storage This medicinal product does not require any special storage conditions. For storage condition after first opening of the medicinal product, see section 6.3.
Drug group (ATC) Centrally acting sympathomimetics:
  1. N Nervous system drugs
    1. N06 Psychoanaleptics
      1. N06B Psychostimulants, agents used for ADHD and nootropics
        1. N06BA Centrally acting sympathomimetics
          1. N06BA04 methylphenidate
Marketing authorisation PL 04416/1348 (first authorised 8 November 2013)
Marketing authorisation holder Sandoz Limited
Codes GTIN 5050650122022, 7622436130033 · BNF 04040000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.